OGN vs XENE: stock comparison and AI forecast
Organon & Co. (OGN) and Xenon Pharmaceuticals Inc. (XENE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
OGN Organon & Co.
- Price
- $13.84 +4.5% · 6M
- Market Cap
- $3.63B
- P/E Ratio
- 19.5x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
XENE Xenon Pharmaceuticals Inc.
- Price
- $37.62 -34.5% · 6M
- Market Cap
- $3.64B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- OGN and XENE have similar market capitalizations ($3.63B and $3.64B).
- Over the last six months OGN returned +4.5% and XENE -34.5%.
- OGN carries 10.23 times debt per unit of equity, against 0.04 times for XENE.
- OGN yields 4.51% in dividends; XENE pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | OGN | XENE |
|---|---|---|
| Market Cap | $3.63B | $3.64B |
| P/E Ratio | 19.49x | – |
| P/B Ratio | 3.05x | 2.93x |
| Dividend Yield | 4.51% | – |
| EPS | $0.71 | $-5.57 |
| Book Value/Share | $4.54 | $12.83 |
| Revenue/Share | $23.22 | $0.00 |
| FCF/Share | $2.57 | $-3.50 |
Profitability & Margins
| Metric | OGN | XENE |
|---|---|---|
| ROE | 17.9% | -32.9% |
| ROA | 1.6% | -31.6% |
| ROIC | – | -35.3% |
| Gross Margin | 53.1% | – |
| Net Margin | 3.5% | – |
| EBT Margin | 8.2% | – |
| Tax Rate | 57.6% | 0.5% |
Financial Health
| Metric | OGN | XENE |
|---|---|---|
| Current Ratio | 2.02x | 21.02x |
| Quick Ratio | 1.51x | – |
| D/E Ratio | 10.23x | 0.04x |
| Financial Leverage | 11.23x | 1.04x |
| Interest Coverage | – | -4.2x |
| Working Capital | $2.72B | $901M |
Cash Flow
| Metric | OGN | XENE |
|---|---|---|
| Operating Cash Flow | $843M | -$338M |
| Free Cash Flow | $675M | -$339M |
| Capital Spending | -$168M | -$1M |
| OCF Growth YoY | -11.2% | – |
| FCF Growth YoY | -13.1% | – |
| FCF/Sales | 11.1% | – |
| CapEx/Sales | 2.8% | – |
Operational Efficiency
| Metric | OGN | XENE |
|---|---|---|
| Asset Turnover | 0.46x | 0.00x |
| Receivables Turnover | 4.1x | – |
| Inventory Turnover | 2.1x | – |
| Fixed Assets Turnover | 4.7x | 0.0x |
| Days Sales Outstanding | 89 days | – |
| Days Inventory | 173 days | – |
| Payables Period | 125 days | – |
| Cash Conversion Cycle | 136 days | – |
Income Statement
| Metric | OGN | XENE |
|---|---|---|
| Total Revenue | $6.10B | $0.00M |
| Operating Income | – | -$442M |
| Net Income | $213M | -$409M |
| R&D Expense | $357M | $352M |
| SG&A Expense | $1.71B | – |
| Cost of Goods Sold | $2.86B | – |
Dividend & Shareholder Information
| Metric | OGN | XENE |
|---|---|---|
| Dividends Per Share | $0.62 | – |
| Payout Ratio | 87.3% | – |
| Shares Outstanding | 263M | 97M |
| Net Income Growth | -57.5% | – |
| EPS Growth | -60.8% | – |
OGN vs XENE: stock comparison and AI forecast
Which is bigger, OGN or XENE?
OGN and XENE have similar market capitalizations ($3.63B and $3.64B).
Which stock performed better over the last six months, OGN or XENE?
Over the last six months OGN returned +4.5% and XENE -34.5%.
Which one does Intratio's AI model rank higher, OGN or XENE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.